Cargando…
Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism
Serine proteases (SPs) are typically synthesized as precursors, termed proenzymes or zymogens, and the fully active form is produced via limited proteolysis by another protease or by autoactivation. The lectin pathway of the complement system is initiated by mannose-binding lectin (MBL)-associated S...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741598/ https://www.ncbi.nlm.nih.gov/pubmed/29326707 http://dx.doi.org/10.3389/fimmu.2017.01821 |
_version_ | 1783288206678032384 |
---|---|
author | Oroszlán, Gábor Dani, Ráhel Szilágyi, András Závodszky, Péter Thiel, Steffen Gál, Péter Dobó, József |
author_facet | Oroszlán, Gábor Dani, Ráhel Szilágyi, András Závodszky, Péter Thiel, Steffen Gál, Péter Dobó, József |
author_sort | Oroszlán, Gábor |
collection | PubMed |
description | Serine proteases (SPs) are typically synthesized as precursors, termed proenzymes or zymogens, and the fully active form is produced via limited proteolysis by another protease or by autoactivation. The lectin pathway of the complement system is initiated by mannose-binding lectin (MBL)-associated SPs (MASP)-1, and MASP-2, which are known to be present as proenzymes in blood. The third SP of the lectin pathway, MASP-3, was recently shown to be the major activator, and the exclusive “resting blood” activator of profactor D, producing factor D, the initiator protease of the alternative pathway. Because only activated MASP-3 is capable of carrying out this cleavage, it was presumed that a significant fraction of MASP-3 must be present in the active form in resting blood. Here, we aimed to detect active MASP-3 in the blood by a more direct technique and to quantitate the active to zymogen ratio. First, MASPs were partially purified (enriched) from human plasma samples by affinity chromatography using immobilized MBL in the presence of inhibitors. Using this MASP pool, only the zymogen form of MASP-1 was detected by Western blot, whereas over 70% MASP-3 was in an activated form in the same samples. Furthermore, the active to zymogen ratio of MASP-3 showed little individual variation. It is enigmatic how MASP-3, which is not able to autoactivate, is present mostly as an active enzyme, whereas MASP-1, which has a potent autoactivation capability, is predominantly proenzymic in resting blood. In an attempt to explain this phenomenon, we modeled the basal level fluid-phase activation of lectin pathway proteases and their subsequent inactivation by C1 inhibitor and antithrombin using available and newly determined kinetic constants. The model can explain extensive MASP-3 activation only if we assume efficient intracomplex activation of MASP-3 by zymogen MASP-1. On the other hand, the model is in good agreement with the fact that MASP-1 and -2 are predominantly proenzymic and some of them is present in the form of inactive serpin–protease complexes. As an alternative hypothesis, MASP-3 activation by proprotein convertases is also discussed. |
format | Online Article Text |
id | pubmed-5741598 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57415982018-01-11 Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism Oroszlán, Gábor Dani, Ráhel Szilágyi, András Závodszky, Péter Thiel, Steffen Gál, Péter Dobó, József Front Immunol Immunology Serine proteases (SPs) are typically synthesized as precursors, termed proenzymes or zymogens, and the fully active form is produced via limited proteolysis by another protease or by autoactivation. The lectin pathway of the complement system is initiated by mannose-binding lectin (MBL)-associated SPs (MASP)-1, and MASP-2, which are known to be present as proenzymes in blood. The third SP of the lectin pathway, MASP-3, was recently shown to be the major activator, and the exclusive “resting blood” activator of profactor D, producing factor D, the initiator protease of the alternative pathway. Because only activated MASP-3 is capable of carrying out this cleavage, it was presumed that a significant fraction of MASP-3 must be present in the active form in resting blood. Here, we aimed to detect active MASP-3 in the blood by a more direct technique and to quantitate the active to zymogen ratio. First, MASPs were partially purified (enriched) from human plasma samples by affinity chromatography using immobilized MBL in the presence of inhibitors. Using this MASP pool, only the zymogen form of MASP-1 was detected by Western blot, whereas over 70% MASP-3 was in an activated form in the same samples. Furthermore, the active to zymogen ratio of MASP-3 showed little individual variation. It is enigmatic how MASP-3, which is not able to autoactivate, is present mostly as an active enzyme, whereas MASP-1, which has a potent autoactivation capability, is predominantly proenzymic in resting blood. In an attempt to explain this phenomenon, we modeled the basal level fluid-phase activation of lectin pathway proteases and their subsequent inactivation by C1 inhibitor and antithrombin using available and newly determined kinetic constants. The model can explain extensive MASP-3 activation only if we assume efficient intracomplex activation of MASP-3 by zymogen MASP-1. On the other hand, the model is in good agreement with the fact that MASP-1 and -2 are predominantly proenzymic and some of them is present in the form of inactive serpin–protease complexes. As an alternative hypothesis, MASP-3 activation by proprotein convertases is also discussed. Frontiers Media S.A. 2017-12-18 /pmc/articles/PMC5741598/ /pubmed/29326707 http://dx.doi.org/10.3389/fimmu.2017.01821 Text en Copyright © 2017 Oroszlán, Dani, Szilágyi, Závodszky, Thiel, Gál and Dobó. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Oroszlán, Gábor Dani, Ráhel Szilágyi, András Závodszky, Péter Thiel, Steffen Gál, Péter Dobó, József Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism |
title | Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism |
title_full | Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism |
title_fullStr | Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism |
title_full_unstemmed | Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism |
title_short | Extensive Basal Level Activation of Complement Mannose-Binding Lectin-Associated Serine Protease-3: Kinetic Modeling of Lectin Pathway Activation Provides Possible Mechanism |
title_sort | extensive basal level activation of complement mannose-binding lectin-associated serine protease-3: kinetic modeling of lectin pathway activation provides possible mechanism |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5741598/ https://www.ncbi.nlm.nih.gov/pubmed/29326707 http://dx.doi.org/10.3389/fimmu.2017.01821 |
work_keys_str_mv | AT oroszlangabor extensivebasallevelactivationofcomplementmannosebindinglectinassociatedserineprotease3kineticmodelingoflectinpathwayactivationprovidespossiblemechanism AT danirahel extensivebasallevelactivationofcomplementmannosebindinglectinassociatedserineprotease3kineticmodelingoflectinpathwayactivationprovidespossiblemechanism AT szilagyiandras extensivebasallevelactivationofcomplementmannosebindinglectinassociatedserineprotease3kineticmodelingoflectinpathwayactivationprovidespossiblemechanism AT zavodszkypeter extensivebasallevelactivationofcomplementmannosebindinglectinassociatedserineprotease3kineticmodelingoflectinpathwayactivationprovidespossiblemechanism AT thielsteffen extensivebasallevelactivationofcomplementmannosebindinglectinassociatedserineprotease3kineticmodelingoflectinpathwayactivationprovidespossiblemechanism AT galpeter extensivebasallevelactivationofcomplementmannosebindinglectinassociatedserineprotease3kineticmodelingoflectinpathwayactivationprovidespossiblemechanism AT dobojozsef extensivebasallevelactivationofcomplementmannosebindinglectinassociatedserineprotease3kineticmodelingoflectinpathwayactivationprovidespossiblemechanism |